Recovery Act Funding at NCI
The National Cancer Institute (NCI) received nearly $1.3 billion in Recovery Act funds to be distributed during the two-year span of 2009 and 2010. The Recovery Act dictates that NCI fund programs that preserve and create jobs and promote economic recovery, assist those most impacted by the recession, and provide investments to increase economic efficiency by spurring technological advances in science and health.
Working under these parameters, NCI is identifying appropriate programs that provide the greatest opportunities to realize scientific impacts in short periods of time.
NCI's initial push has been to fund additional grants already in the 2009 pipeline, made possible by increasing the grant payline. New research is being funded through payline increases and the expansion of promising programs.
Bar Graph that depicts approximate dollars in Recovery Act awards for programs of note. The funding amounts for ACTNOW is $36,000,000. The funding amounts for Cancer Centers (P30's) is $ 63,000,000. The funding amounts for TCGA is $ 150,000,000. The funding amounts for TARGET is $ 25,000,000. The funding amounts for CaHUB is $ 60,000,000. The funding amounts for NCCCP is $ 80,000,000.
The following is an Adobe Flash depiction of this data.
Programs Receiving FundingPrograms of note that are receiving Recovery Act funds through NCI include:
Accelerating Clinical Trials of Novel Oncologic PathWays (ACTNOW)
Funding 37 promising clinical trials of molecularly-targeted therapies to speed the delivery of personalized cancer treatments to patients.
Cancer Centers Program (P30 Grants)
62 NCI-designated Cancer Centers across the country received $63 million in ARRA funding to supplement Cancer Center Support Grants (P30).
Personalized Cancer Care / Drug Development Platform
Enabling drug development that begins with the discovery of genetic changes and ends with targeted cancer therapies. Programs that support this vision include:
- The Cancer Genome Atlas (TCGA) is developing a comprehensive catalog of genomic changes found in adult cancers;
- Therapeutically Applicable Research to Generate Effective Treatments (TARGET) is mapping the genetic changes associated with childhood cancers;
- The Cancer Human Biobank (caHUB) leads quality biospecimen collection and management;
- The NCI Community Cancer Centers Program (NCCCP) involves patients around the country who provide data and volunteer for clinical trials.
Physical Sciences in Oncology Centers
Exploring perspectives from the physical sciences to enhance our understanding of cancer biology.
Visit the Funding Awards section to get the latest information on Recovery Act funding allocations.
The Recovery Act funding mechanisms that were used for distributing the funds can be viewed on NCI's Recovery Act Funding Announcements page.